Franchise Lead - Hematology

Working with Us

Challenging. Meaningful. Life-changing. Those aren’t words that are usually associated with a job. But working at Bristol Myers Squibb is anything but usual. Here, uniquely interesting work happens every day, in every department. From optimizing a production line to the latest breakthroughs in cell therapy, this is work that transforms the lives of patients, and the careers of those who do it. You’ll get the chance to grow and thrive through opportunities uncommon in scale and scope, alongside high-achieving teams. Take your career farther than you thought possible.

Bristol Myers Squibb recognizes the importance of balance and flexibility in our work environment. We offer a wide variety of competitive benefits, services and programs that provide our employees with the resources to pursue their goals, both at work and in their personal lives. Read more: careers.bms.com/working-with-us.

Bristol Myers Squibb es un empleador que brinda igualdad de oportunidades. Las personas que apliquen para cualquier vacante, y que estén calificadas para la misma recibirán consideración para el empleo sin distinción de raza, color, religión, sexo, orientación sexual, identidad de género, nacionalidad, edad, discapacidad, condición de veterano protegido, embarazo, ciudadanía, estado civil, expresión de género, información genética, afiliación política o cualquier otra característica protegida por la ley.

Key Responsibilities

• Execute the annual franchise strategic and commercial plan (per quarter and per year) to meet the Hematology revenue and launch commitments, in alignment with the direction set by the Head of Commercial.
• Support portfolio prioritization and manage resource allocation across in-line and pipeline assets within the approved budget.
• Prepare business reviews, brand plans, and business cases with cross-functional teams for review.
• Develop and execute the UBP (8 Strategic Choices) for CELMoDs Mexico as the Decision Maker (D) under the DAI model.
• Deliver P1–P3 UBP Updates, applying the 7 Key Business Questions to adapt the plan to market learnings.
• Manage the 360° Brand Plan for CELMoDs — pre-launch market shaping, launch, execution, and post-launch optimization across public and private sectors.
• Integrate CELMoDs and Reblozyl plans into a coherent franchise recommendation for the Head of Commercial's approval.
• Lead and coordinate launch readiness and execution for CELMoDs (Iberdomide MM, best-case Q1 2027; Mezigdomide 2028; Golcadomide 2029) and Breyanzi CAR-T (2028 assumption).
• Coordinate immersion workshops, launch execution, and stakeholder communication across MM and Lymphoma.
• Lead, coach, and develop the Reblozyl Brand Lead and the Hematology District Manager (who leads the TAS field team).
• Set performance objectives, drive development plans, and support talent, succession, and capability building.
• Foster a high-performance, AI-enabled, patient-centric culture.
• Develop and execute the annual franchise strategic and commercial plan (per quarter and per year) to meet the Hematology revenue and launch commitments, in alignment with the direction set by the Head of Commercial.
• Support portfolio prioritization and manage resource allocation across in-line and pipeline assets within the approved budget.
• Prepare business reviews, brand plans, and business cases with cross-functional teams for review.
• Develop and execute the UBP (8 Strategic Choices) for CELMoDs Mexico as the Decision Maker (D) under the DAI model.
• Deliver P1–P3 UBP Updates, applying the 7 Key Business Questions to adapt the plan to market learnings.
• Manage the 360° Brand Plan for CELMoDs — pre-launch market shaping, launch, execution, and post-launch optimization across public and private sectors.
• Integrate CELMoDs and Reblozyl plans into a coherent franchise recommendation for the Head of Commercial's approval.
• Lead and coordinate launch readiness and execution for CELMoDs (Iberdomide MM, best-case Q1 2027; Mezigdomide 2028; Golcadomide 2029) and Breyanzi CAR-T (2028 assumption).
• Coordinate immersion workshops, launch execution, and stakeholder communication across MM and Lymphoma.
• Lead, coach, and develop the Reblozyl Brand Lead and the Hematology District Manager (who leads the TAS field team).
• Set performance objectives, drive development plans, and support talent, succession, and capability building.
• Foster a high-performance, AI-enabled, patient-centric culture.
• Develop and execute the annual franchise strategic and commercial plan (per quarter and per year) to meet the Hematology revenue and launch commitments, in alignment with the direction set by the Head of Commercial.
• Support portfolio prioritization and manage resource allocation across in-line and pipeline assets within the approved budget.
• Prepare business reviews, brand plans, and business cases with cross-functional teams for review.
• Develop and execute the UBP (8 Strategic Choices) for CELMoDs Mexico as the Decision Maker (D) under the DAI model.
• Deliver P1–P3 UBP Updates, applying the 7 Key Business Questions to adapt the plan to market learnings.
• Manage the 360° Brand Plan for CELMoDs — pre-launch market shaping, launch, execution, and post-launch optimization across public and private sectors.
• Integrate CELMoDs and Reblozyl plans into a coherent franchise recommendation for the Head of Commercial's approval.
• Lead and coordinate launch readiness and execution for CELMoDs (Iberdomide MM, best-case Q1 2027; Mezigdomide 2028; Golcadomide 2029) and Breyanzi CAR-T (2028 assumption).
• Coordinate immersion workshops, launch execution, and stakeholder communication across MM and Lymphoma.
• Lead, coach, and develop the Reblozyl Brand Lead and the Hematology District Manager (who leads the TAS field team).
• Set performance objectives, drive development plans, and support talent, succession, and capability building.
• Foster a high-performance, AI-enabled, patient-centric culture.

Qualifications

• Required: Bachelor's degree in Life Sciences, Business, Pharmacy, Medicine, or related field; MBA/advanced degree preferred.
• 7+ years progressive pharmaceutical commercial/marketing experience; 3+ years in Brand/Franchise Management.
• Hematology experience preferred; Oncology experience desired.
• Demonstrated experience leading teams.
• Demonstrated launch experience in Mexico (hematology/oncology preferred).
• Working understanding of Mexican public sector (IMSS, ISSSTE, IMSS-Bienestar, tenders) and private-sector dynamics.
• Ability to lead and influence in a matrix environment without direct authority.
• Strong commercial acumen: forecasting, GTM planning, performance management, budget accuracy.
• Fluent Spanish and professional working English.